These modern medical treatments were developed to mimic this hormone and support better management of Type 2 diabetes
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS, DECLARETIMI 58 Investigators
Patients administer the medicine via subcutaneous injection once weekly with dosages starting at 2.5mg and typically going up to 5mg, 10mg, or 15mg, depending on the doctors recommendation and patients response
The receptor agonists can bind to the GLP-1 receptors to mimic natural GLP-1 and stay in the blood much longer
List of Key Companies Takeda Novo Nordisk Pfizer Eli Lilly Janssen Pharmaceuticals Astellas Boehringer Ingelheim Merck And Co